{"id":3363,"date":"2022-08-11T14:31:13","date_gmt":"2022-08-11T12:31:13","guid":{"rendered":"https:\/\/www.hopital-marmottan.fr\/wordpress\/?p=3363"},"modified":"2022-08-11T14:31:13","modified_gmt":"2022-08-11T12:31:13","slug":"nouveaux-produits-de-synthese-la-mildeca-actualise-son-guide-pour-une-meilleure-prise-en-charge","status":"publish","type":"post","link":"https:\/\/www.hopital-marmottan.fr\/wordpress\/?p=3363","title":{"rendered":"Nouveaux produits de synth\u00e8se : la MILDECA actualise son guide pour une meilleure prise en charge"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Depuis 2015, chaque ann\u00e9e, 400 nouveaux produits de synth\u00e8ses sont recens\u00e9s en Europe. En France, ce sont pr\u00e8s de 200 mol\u00e9cules qui sont r\u00e9pertori\u00e9es, principalement des cathinones (stimulants), des cannabino\u00efdes de synth\u00e8se et des ph\u00e9n\u00e9thylamines (hallucinog\u00e8nes).<\/strong> <strong>La MILDECA actualise son guide pour r\u00e9pondre aux enjeux sp\u00e9cifiques li\u00e9s \u00e0 la pr\u00e9vention et \u00e0 la prise en charge en cas d\u2019intoxication \u00e0 ces produits.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tout comme l\u2019\u00e9dition 2016, cette nouvelle version 2022 vise \u00e0 l\u2019exhaustivit\u00e9 des substances recens\u00e9es. Dans ce guide sont list\u00e9es \u00e0 la fois les nouvelles substances psychoactives (NSP\/NPS en anglais) et les nouveaux produits de synth\u00e8se, c\u2019est-\u00e0-dire \u00ab les substances psychoactives nouvellement arriv\u00e9es sur le march\u00e9, naturelles ou synth\u00e9tiques, class\u00e9es ou non produits stup\u00e9fiants ou psychotropes dans les conventions internationales \u00bb. Ce guide pr\u00e9sente \u00e9galement un protocole accompagnant la prise en charge th\u00e9rapeutique lors d&rsquo;une suspicion d&rsquo;intoxication \u00e0 l\u2019un de ces produits. Enfin, il recense la liste des centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance-addictovigilance (CEIP-A).<\/p>\n\n\n\n<p class=\"has-text-align-left wp-block-paragraph\"><strong><a href=\"https:\/\/www.drogues.gouv.fr\/nouveaux-produits-de-synthese-un-guide-actualise-et-une-appli-pour-une-meilleure-prise-en-charge\" data-type=\"URL\" data-id=\"https:\/\/www.drogues.gouv.fr\/nouveaux-produits-de-synthese-un-guide-actualise-et-une-appli-pour-une-meilleure-prise-en-charge\">&#8212; Acc\u00e9der au guide &#8212;<\/a><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ce guide a \u00e9t\u00e9 impuls\u00e9 par la MILDECA et r\u00e9dig\u00e9 sous la direction de Laurent Karila (Universit\u00e9 Paris Saclay) et de l\u2019association ELSA France qui en assurera la diffusion.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Depuis 2015, chaque ann\u00e9e, 400 nouveaux produits de synth\u00e8ses sont recens\u00e9s en Europe. En France, ce sont pr\u00e8s de 200 mol\u00e9cules qui sont r\u00e9pertori\u00e9es, principalement des cathinones (stimulants), des cannabino\u00efdes de synth\u00e8se et des ph\u00e9n\u00e9thylamines (hallucinog\u00e8nes). La MILDECA actualise son &hellip; <a href=\"https:\/\/www.hopital-marmottan.fr\/wordpress\/?p=3363\">Continuer la lecture <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[542,497],"tags":[370,585,266,142,19],"class_list":["post-3363","post","type-post","status-publish","format-standard","hentry","category-bibliographie","category-publications","tag-guide","tag-mildeca","tag-nouveaux-produits-de-synthese","tag-nps","tag-prise-en-charge"],"_links":{"self":[{"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/3363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3363"}],"version-history":[{"count":3,"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/3363\/revisions"}],"predecessor-version":[{"id":3366,"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/3363\/revisions\/3366"}],"wp:attachment":[{"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hopital-marmottan.fr\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}